MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
Pretreatment assessment of cytogenetic/genetic signature of acute myeloid leukemia (AML) has been consistently shown to play a major prognostic role but also to fail at predicting outcome on individual basis, even in low-risk AML. Therefore, we are in need of further accurate methods to refine the p...
Saved in:
| Main Author: | Maria Ilaria Del Principe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2016-10-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY
by: Daichi Inoue, et al.
Published: (2010-08-01) -
Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia
by: Fatima Hameed Ahmad, et al.
Published: (2024-09-01) -
Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01) -
CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
by: Juliana Maria Camargos Rocha, et al.
Published: (2016-04-01) -
Immunophenotypic investigation of infant acute myeloid leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)